Integrated Market Access Strategies Are Needed Now More Than Ever

Innovation in the pharma/life sciences arena has brought a shift toward targeted, often high-cost therapies aimed at smaller patient populations. These therapies require a comprehensive, unified market access strategy to ensure access for patients and to optimize brand success.

In this latest article, Ellen Cappellino, SVP, Market Access & Patient Services for EVERSANA, discusses how to integrate people, technology, real-world data and infrastructure to develop market access strategies that address:

  • Administrative barriers that impede patient access
  • Financial barriers that create challenges in affordability
  • Clinical barriers that hinder patient adherence

Request Free!